mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.045 |
0.4 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.25 |
0.4 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |